Primary central nervous system lymphoma (PCNSL) is a rare extranodal lymphomatous
malignancy that affects the brain, spinal cord, leptomeninges, or vitreoretinal space, without …

Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …

Summary Background The International Extranodal Lymphoma Study Group-32 (IELSG32)
trial is an international randomised phase 2 study that addresses two key clinical questions …

Background There has been significant improvement in treatment outcomes of primary
central nervous system lymphoma (PCNSL) at specialized centers over the past several …

Objective Real-life studies on patients with primary CNS lymphoma (PCNSL) are scarce.
Our objective was to analyze, in a nationwide population-based study, the current medical …

Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal
non‐Hodgkin lymphoma (NHL) that is confined to the brain, eyes, spinal cord, or …

Vitreoretinal lymphoma (VRL) is a subtype of diffuse large B-cell lymphoma and is sight-and
life-threatening in the vast majority of patients. Lymphoma cells infiltrate the vitreous body …

Primary diffuse large B-cell (DLBCL) lymphoma of the central nervous system
(CNS)(PCNSL) is a new lymphoma entity, recognized by the 2017 WHO classification of …

People living with HIV or AIDS are at increased risk of Hodgkin and non-Hodgkin lymphoma
compared with HIV-negative individuals. Data on the risk of multiple myeloma or leukaemia …

The genetic alterations that define primary central nervous system lymphoma (PCNSL) are
incompletely elucidated, and the genomic evolution from diagnosis to relapse is poorly …